Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTs
Abstract Aims Guidelines recommend the use of an implantable cardioverter‐defibrillator (ICD) and/or cardiac resynchronization therapy (CRT) device based on the results of randomized controlled trials (RCTs), typically with selected patients and short follow‐up. Methods and results We describe the 5...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-08-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.13357 |
| _version_ | 1823934967443357696 |
|---|---|
| author | Alex Bottle Puji Faitna Paul Aylin Martin R. Cowie |
| author_facet | Alex Bottle Puji Faitna Paul Aylin Martin R. Cowie |
| author_sort | Alex Bottle |
| collection | DOAJ |
| description | Abstract Aims Guidelines recommend the use of an implantable cardioverter‐defibrillator (ICD) and/or cardiac resynchronization therapy (CRT) device based on the results of randomized controlled trials (RCTs), typically with selected patients and short follow‐up. Methods and results We describe the 5 year survival rate and use of hospital services following ICD and CRT implantation in England from April 2011 to March 2013 using the national hospital administrative database covering emergency department visits, inpatient admissions, and clinic appointments, linked to the national death register. Five‐year survival was 64% after ICD implantation and 58% after CRT implantation, with median survival times of 6.8 and 6.2 years, respectively. Hospital use was high in both device groups, for the 5 years prior and after implantation, peaking around the implantation date. Most hospital activity was not primarily related to heart failure. Healthcare costs were dominated by admissions, but emergency department and clinic activity were both high. Only the CRT group saw total per‐patient costs fall after the index month (implantation), driven by a slight fall in the heart failure admission rate. Patients were typically older than in the trials, but with similar co‐morbidity except for substantially more atrial fibrillation and less dementia. Survival and device complications were similar to the RCTs. Conclusions Clinical and cost‐effectiveness assessments of ICD and CRT implantation are supported by real‐world data, although the prevalence of atrial fibrillation remains substantially higher than in the RCTs. |
| first_indexed | 2024-12-16T22:28:25Z |
| format | Article |
| id | doaj.art-a7951388bb344e4eb28b93581aeeb4dc |
| institution | Directory Open Access Journal |
| issn | 2055-5822 |
| language | English |
| last_indexed | 2024-12-16T22:28:25Z |
| publishDate | 2021-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj.art-a7951388bb344e4eb28b93581aeeb4dc2022-12-21T22:13:49ZengWileyESC Heart Failure2055-58222021-08-01842438244710.1002/ehf2.13357Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTsAlex Bottle0Puji Faitna1Paul Aylin2Martin R. Cowie3Dr Foster Unit, School of Public Health, Faculty of Medicine Imperial College London London UKDr Foster Unit, School of Public Health, Faculty of Medicine Imperial College London London UKDr Foster Unit, School of Public Health, Faculty of Medicine Imperial College London London UKNational Heart and Lung Institute, Faculty of Medicine Imperial College London Dovehouse Street London SW3 6LY UKAbstract Aims Guidelines recommend the use of an implantable cardioverter‐defibrillator (ICD) and/or cardiac resynchronization therapy (CRT) device based on the results of randomized controlled trials (RCTs), typically with selected patients and short follow‐up. Methods and results We describe the 5 year survival rate and use of hospital services following ICD and CRT implantation in England from April 2011 to March 2013 using the national hospital administrative database covering emergency department visits, inpatient admissions, and clinic appointments, linked to the national death register. Five‐year survival was 64% after ICD implantation and 58% after CRT implantation, with median survival times of 6.8 and 6.2 years, respectively. Hospital use was high in both device groups, for the 5 years prior and after implantation, peaking around the implantation date. Most hospital activity was not primarily related to heart failure. Healthcare costs were dominated by admissions, but emergency department and clinic activity were both high. Only the CRT group saw total per‐patient costs fall after the index month (implantation), driven by a slight fall in the heart failure admission rate. Patients were typically older than in the trials, but with similar co‐morbidity except for substantially more atrial fibrillation and less dementia. Survival and device complications were similar to the RCTs. Conclusions Clinical and cost‐effectiveness assessments of ICD and CRT implantation are supported by real‐world data, although the prevalence of atrial fibrillation remains substantially higher than in the RCTs.https://doi.org/10.1002/ehf2.13357Heart failureImplantable cardioverter‐defibrillator (ICD)Cardiac resynchronization therapy (CRT)Cardiac implantable electronic devicesAdministrative dataReal‐world data |
| spellingShingle | Alex Bottle Puji Faitna Paul Aylin Martin R. Cowie Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTs ESC Heart Failure Heart failure Implantable cardioverter‐defibrillator (ICD) Cardiac resynchronization therapy (CRT) Cardiac implantable electronic devices Administrative data Real‐world data |
| title | Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTs |
| title_full | Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTs |
| title_fullStr | Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTs |
| title_full_unstemmed | Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTs |
| title_short | Five‐year survival and use of hospital services following ICD and CRT implantation: comparing real‐world data with RCTs |
| title_sort | five year survival and use of hospital services following icd and crt implantation comparing real world data with rcts |
| topic | Heart failure Implantable cardioverter‐defibrillator (ICD) Cardiac resynchronization therapy (CRT) Cardiac implantable electronic devices Administrative data Real‐world data |
| url | https://doi.org/10.1002/ehf2.13357 |
| work_keys_str_mv | AT alexbottle fiveyearsurvivalanduseofhospitalservicesfollowingicdandcrtimplantationcomparingrealworlddatawithrcts AT pujifaitna fiveyearsurvivalanduseofhospitalservicesfollowingicdandcrtimplantationcomparingrealworlddatawithrcts AT paulaylin fiveyearsurvivalanduseofhospitalservicesfollowingicdandcrtimplantationcomparingrealworlddatawithrcts AT martinrcowie fiveyearsurvivalanduseofhospitalservicesfollowingicdandcrtimplantationcomparingrealworlddatawithrcts |